LIFECORE BIOMEDICAL, INC. Stock Repurchase Program, Authorized Amount
LIFECORE BIOMEDICAL, INC. (LFCR) had Stock Repurchase Program, Authorized Amount of $3.80 million as of 2023-02-26, per its 10-Q filed 2023-06-02.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-03-20
- 2023-02-26: Stock Repurchase Program, Authorized Amount $3.80M.
- 2022-11-27: Stock Repurchase Program, Authorized Amount $3.80M.
- 2022-08-28: Stock Repurchase Program, Authorized Amount $3.80M.
- 2022-02-27: Stock Repurchase Program, Authorized Amount $3.80M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2023-02-26 | $3.80M 10-Q · filed 2023-06-02 |
| 2022-11-27 | $3.80M 10-Q · filed 2023-03-16 |
| 2022-08-28 | $3.80M 10-Q/A · filed 2023-03-16 |
| 2022-02-27 | $3.80M 10-Q · filed 2022-04-07 |
| 2021-11-28 | $3.80M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $3.80M 10-Q · filed 2021-10-05 |
| 2021-02-28 | $3.80M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $3.80M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $3.80M 10-Q · filed 2020-10-07 |
| 2018-11-25 | $10.00M 10-Q · filed 2019-01-07 |
| 2018-08-26 | $10.00M 10-Q · filed 2018-10-05 |
| 2010-07-14 | $10.00M 10-K · filed 2024-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |